デフォルト表紙
市場調査レポート
商品コード
1414671

白斑治療の世界市場レポート 2024年

Vitiligo Treatment Global Market Report 2024

出版日: 受注後更新 | 発行: The Business Research Company | ページ情報: 英文 200 Pages | 納期: 2~10営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.36円
白斑治療の世界市場レポート 2024年
出版日: 受注後更新
発行: The Business Research Company
ページ情報: 英文 200 Pages
納期: 2~10営業日
ご注意事項 :
本レポートの納品は、最新情報反映のため受注時に適宜更新しお届けいたします。
更新情報の反映作業にあたり納期もレポート毎に異なりますので、ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

白斑治療の市場規模は近年力強く成長しています。2023年の14億9,000万米ドルから2024年には15億9,000万米ドルへとCAGR6.5%で拡大します。過去の調査期間中に見られた増加は、白斑の発生率の増加、皮膚科学研究の進歩、患者意識の向上、多様な治療法、ヘルスケアにおける患者中心のアプローチによるものです。

白斑治療市場規模は、今後数年間で力強い成長が見込まれます。2028年にはCAGR6.0%で20億米ドルに成長します。予測期間中に予想される増加は、免疫調節療法の進歩、研究資金の増加、皮膚科疾患に対処する世界ヘルスイニシアチブ、併用療法の採用増加、皮膚科治療のインフラ整備などに起因しています。予測期間中に予想される主な動向としては、併用療法の利用、進行中の研究開発、患者中心のアプローチ、世界の意識の高まりと支持、規制状況の発展などが挙げられます。

白斑治療市場の成長は、ヘルスケア支出の増加によって促進されると予想されます。ヘルスケア支出には、健康サービス、家族計画、栄養、緊急支援に関連するすべての費用が含まれ、全体的な健康増進に重点が置かれています。ヘルスケア支出の増加は、尋常性白斑に罹患した人々への改善された治療の提供を強化します。さらに、効果的なプライマリーヘルスケアのイニシアチブは、プライマリーケアサービスを公衆衛生の取り組みと統合することで、集団の健康に貢献します。例えば、米国保健社会福祉省の一部門であるメディケア&メディケイドサービスセンターが発表した2021-2030年国民医療費(NHE)報告書によれば、国民医療費の年間成長率は2021年から2030年まで平均5.1%で、2030年には推定6兆8,000億米ドルに達すると予測されています。同期間中、メディケア支出は年率7.2%、メディケイド支出は年率5.6%で増加すると予測されています。その結果、ヘルスケア支出の急増が白斑治療市場成長の原動力となっています。

尋常性白斑の有病率の増加は市場の成長を促進します。白斑は、特定の皮膚領域における色素産生細胞(メラノサイト)の消失を特徴とし、その結果、白い斑点が形成されます。新たな治療法を求めて積極的に採用する白斑患者の増加と、利用可能な選択肢に対する意識の高まりが、製薬企業の研究開発投資を後押ししています。米国を拠点に白斑研究の推進に取り組むGlobal Vitiligo Foundationによると、2021年には世界で約7,000万人が白斑に罹患し、患者の20~30%は小児です。そのため、今後予想されるヘルスケア支出の増加は、白斑治療市場成長の大きな促進要因となっています。

北米は2023年の世界の白斑治療市場において最大の地域でした。アジア太平洋は予測期間中に最も急成長する地域となる見込みです。白斑治療市場レポート対象地域は、アジア太平洋,西欧,東欧,北米,南米,中東,アフリカです。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

  • 高インフレが市場に与える影響
  • ウクライナ・ロシア戦争が市場に与える影響
  • COVID-19による市場への影響

第5章 世界市場規模と成長

  • 世界の市場促進要因と抑制要因
    • 市場促進要因
    • 市場抑制要因
  • 世界の市場規模実績と成長、2018年~2023年
  • 世界の市場規模予測と成長、2023年~2028年、2033年

第6章 市場セグメンテーション

  • 世界の白斑治療市場、医薬品別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 抗ヒスタミン薬
  • H2アンタゴニスト
  • 三環系抗うつ薬
  • その他
  • 世界の白斑治療市場、タイプ別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 急性蕁麻疹
  • 慢性蕁麻疹
  • 世界の白斑治療市場、投与方法別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 注射
  • 経口
  • その他
  • 世界の白斑治療市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院薬局
  • 小売薬局
  • オンライン薬局
  • 世界の白斑治療市場、エンドユーザー別のセグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
  • 病院
  • ホームケア
  • 専門クリニック
  • その他

第7章 地域および国の分析

  • 世界の白斑治療市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
  • 世界の白斑治療市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

  • 白斑治療市場の競合情勢
  • 白斑治療市場の企業プロファイル
    • Cliniuvel Pharmaceuticals Ltd.
    • Dr. Reddy's Laboratories Ltd.
    • Pfizer Inc.
    • Incyte Corporation
    • STRATA Skin Sciences

第31章 競合ベンチマーキング

第32章 競合ダッシュボード

第33章 主要な合併と買収

第34章 将来の見通しと可能性の分析

第35章 付録

目次
Product Code: r12181

“Vitiligo Treatment Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on vitiligo treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for vitiligo treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The vitiligo treatment market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

  • 1) By Drugs: Antihistamines; H2 Antagonists; Tricyclic Antidepressants; Other Drugs
  • 2) By Types: Acute Urticaria; Chronic Urticaria
  • 3) By Mode Of Administration: Injectable; Oral; Other Modes Of Administration
  • 4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 5) By End-User: Hospitals; Homecare; Specialty Clinics; Other End-Users
  • Companies Mentioned: Cliniuvel Pharmaceuticals Ltd.; Dr. Reddy's Laboratories Ltd.; Pfizer Inc.; Incyte Corporation; STRATA Skin Sciences
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Vitiligo treatment addresses a chronic autoimmune condition characterized by the loss of pigmentation or color in specific skin regions. These treatments play a crucial role in both halting and reversing the progression of vitiligo.

The primary classes of drugs used in vitiligo treatment include antihistamines, h2 antagonists, tricyclic antidepressants, and others. Antihistamines, which inhibit histamine in the body, are employed to manage reactions to allergens and can also be beneficial in reducing histamine levels in individuals with vitiligo. Treatment options encompass acute urticaria and chronic urticaria, with various administration methods available, including injectable, oral, and others. These treatments are accessible through diverse distribution channels such as hospital pharmacies, retail pharmacies, and online pharmacies. They are utilized by a range of end-users, including hospitals, homecare services, specialty clinics, and others.

The vitiligo treatment market size has grown strongly in recent years. It will grow from $1.49 billion in 2023 to $1.59 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The rise observed in the historical period can be ascribed to a higher incidence of vitiligo, advancements in dermatology research, enhanced patient awareness, a variety of treatment modalities, and a patient-centric approach in healthcare.

The vitiligo treatment market size is expected to see strong growth in the next few years. It will grow to $2 billion in 2028 at a compound annual growth rate (CAGR) of 6.0%. The anticipated increase in the forecast period can be credited to advancements in immunomodulatory therapies, a rise in research funding, global health initiatives addressing dermatological conditions, the increasing adoption of combination therapies, and improved infrastructure for dermatology care. Key trends expected in the forecast period involve the utilization of combination therapies, ongoing research and development efforts, patient-centric approaches, heightened global awareness and advocacy, and developments in the regulatory landscape.

The anticipated growth in the vitiligo treatment market is expected to be propelled by an increase in healthcare expenditure. Healthcare expenditure encompasses all costs associated with delivering health services, family planning, nutrition, and emergency assistance, with a focus on overall health improvement. Elevated healthcare spending is poised to enhance the provision of improved treatment for individuals affected by vitiligo. Furthermore, effective primary healthcare initiatives will contribute to population health by integrating primary care services with public health efforts. For example, as per the 2021-2030 National Health Expenditure (NHE) report released by the Centers for Medicare & Medicaid Services, a department of the US-based Department of Health and Human Services, the annual growth in national health spending is projected to average 5.1% from 2021 to 2030, reaching an estimated $6.8 trillion by 2030. Over the same period, Medicare expenditures are expected to increase at a 7.2% annual rate, while Medicaid spending is projected to grow at a 5.6% annual rate. Consequently, the surge in healthcare expenditure is a driving force behind the growth of the vitiligo treatment market.

The increasing prevalence of vitiligo is set to fuel the market's growth. Vitiligo, characterized by the loss of pigment-producing cells (melanocytes) in specific skin areas, results in the formation of white patches. The growing number of individuals affected by vitiligo actively seeking and adopting new treatments, coupled with a rising awareness of available options, encourages pharmaceutical companies to invest in research and development. According to the Global Vitiligo Foundation, a US-based organization dedicated to advancing vitiligo research, approximately 70 million people worldwide had vitiligo in 2021, with 20-30% of patients being children. Therefore, the anticipated increase in healthcare expenditure is a significant driver of the vitiligo treatment market's growth.

A prevailing trend in the vitiligo treatment market is the emphasis on product innovations. Companies engaged in this market are dedicated to introducing novel products as part of their strategy to maintain a strong market position. For instance, in July 2022, Incyte Corporation, a pharmaceutical firm based in the United States, announced the FDA's approval of OpzeluraTM (ruxolitinib) cream 1.5% for the topical treatment of non-segmental vitiligo in both adult and pediatric patients aged 12 years and older. Opzelura is designed for twice-daily topical application to affected areas covering up to 10% of the body surface area in individuals with non-segmental vitiligo. Patients using Opzelura consistently demonstrated a 75% improvement from baseline in the Face Vitiligo Area Scoring Index (F-VASI75) at Week 24.

Prominent companies in the vitiligo market are focusing on innovative products, such as a self-designed kit for vitiligo preventive treatment. This kit is a personalized range of Ayurvedic products aimed at providing natural solutions for vitiligo. For example, in September 2021, Vedas Cure, an online Ayurveda treatment center based in India, introduced a self-designed kit for vitiligo preventive treatment. The kit comprises Kaishor Guggulu, Derma Care Powder, and Psoralea oil (babchi oil), which is locally applied and proven effective in treating vitiligo by evenly distributing skin color on white patches, thereby minimizing the condition. The kit is formulated to help control the disease's spread, facilitate rapid re-pigmentation, prevent skin discoloration, and alleviate itching, rashes, and inflammation.

In October 2022, Incyte Corp., a U.S.-based pharmaceutical company, completed the acquisition of Villaris Therapeutics Inc. for an undisclosed amount. This strategic move expanded Incyte's existing portfolio and significantly enhanced treatment options for vitiligo patients, leveraging the acquired knowledge. Villaris Therapeutics Inc. is a biopharmaceutical firm based in the United States, specializing in the development of novel treatments for individuals with vitiligo.

Major companies operating in the vitiligo treatment market report are Cliniuvel Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Pfizer Inc., Incyte Corporation, STRATA Skin Sciences, Astellas Pharma Inc., Bausch Health Companies Inc., Arcutis Biotherapeutics, Strides Pharma Science Limited, Mylan N.V., Glenmark Pharmaceuticals Ltd., Clarify Medical Inc., Novartis AG, LEO Pharma A/S, Dermfix Ltd., Bristol-Myers Squibb, Dermavant Science Inc., Merck KGaA, Celgene, Boston Pharmaceuticals, DermTech, Galderma S.A., Allergan Inc., Amgen, Koninklijke Philips N.V., Sun Pharmaceutical Industries Ltd., Thermo Fisher Scientific Inc., Vitiligo Research Foundation, Vitiligo Bond Inc., Vitiligo Society, Vitiligo Clinic and Research Center, Vitiligo Support International

North America was the largest region in the global vitiligo treatment market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vitiligo treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the vitiligo treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The vitiligo treatment market consists of revenues earned by entities by providing moderate-to-high strength topical corticosteroids, calcineurin inhibitors, and drugs including Ruxolitinib. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Table of Contents

1. Executive Summary

2. Vitiligo Treatment Market Characteristics

3. Vitiligo Treatment Market Trends And Strategies

4. Vitiligo Treatment Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On the Market
  • 4.2. Ukraine-Russia War Impact On the Market
  • 4.3. COVID-19 Impact On the Market

5. Global Vitiligo Treatment Market Size and Growth

  • 5.1. Global Vitiligo Treatment Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Vitiligo Treatment Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Vitiligo Treatment Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Vitiligo Treatment Market Segmentation

  • 6.1. Global Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Antihistamines
  • H2 Antagonists
  • Tricyclic Antidepressants
  • Other Drugs
  • 6.2. Global Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Acute Urticaria
  • Chronic Urticaria
  • 6.3. Global Vitiligo Treatment Market, Segmentation By Mode Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Injectable
  • Oral
  • Other Modes Of Administration
  • 6.4. Global Vitiligo Treatment Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • 6.5. Global Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Homecare
  • Specialty Clinics
  • Other End-Users

7. Vitiligo Treatment Market Regional And Country Analysis

  • 7.1. Global Vitiligo Treatment Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Vitiligo Treatment Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Vitiligo Treatment Market

  • 8.1. Asia-Pacific Vitiligo Treatment Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Vitiligo Treatment Market

  • 9.1. China Vitiligo Treatment Market Overview
  • 9.2. China Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Vitiligo Treatment Market

  • 10.1. India Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Vitiligo Treatment Market

  • 11.1. Japan Vitiligo Treatment Market Overview
  • 11.2. Japan Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Vitiligo Treatment Market

  • 12.1. Australia Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Vitiligo Treatment Market

  • 13.1. Indonesia Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Vitiligo Treatment Market

  • 14.1. South Korea Vitiligo Treatment Market Overview
  • 14.2. South Korea Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Vitiligo Treatment Market

  • 15.1. Western Europe Vitiligo Treatment Market Overview
  • 15.2. Western Europe Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Vitiligo Treatment Market

  • 16.1. UK Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Vitiligo Treatment Market

  • 17.1. Germany Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Vitiligo Treatment Market

  • 18.1. France Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Vitiligo Treatment Market

  • 19.1. Italy Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Vitiligo Treatment Market

  • 20.1. Spain Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Vitiligo Treatment Market

  • 21.1. Eastern Europe Vitiligo Treatment Market Overview
  • 21.2. Eastern Europe Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Vitiligo Treatment Market

  • 22.1. Russia Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Vitiligo Treatment Market

  • 23.1. North America Vitiligo Treatment Market Overview
  • 23.2. North America Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Vitiligo Treatment Market

  • 24.1. USA Vitiligo Treatment Market Overview
  • 24.2. USA Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Vitiligo Treatment Market

  • 25.1. Canada Vitiligo Treatment Market Overview
  • 25.2. Canada Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Vitiligo Treatment Market

  • 26.1. South America Vitiligo Treatment Market Overview
  • 26.2. South America Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Vitiligo Treatment Market

  • 27.1. Brazil Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Vitiligo Treatment Market

  • 28.1. Middle East Vitiligo Treatment Market Overview
  • 28.2. Middle East Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Vitiligo Treatment Market

  • 29.1. Africa Vitiligo Treatment Market Overview
  • 29.2. Africa Vitiligo Treatment Market, Segmentation By Drugs, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Vitiligo Treatment Market, Segmentation By Types, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Vitiligo Treatment Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Vitiligo Treatment Market Competitive Landscape And Company Profiles

  • 30.1. Vitiligo Treatment Market Competitive Landscape
  • 30.2. Vitiligo Treatment Market Company Profiles
    • 30.2.1. Cliniuvel Pharmaceuticals Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Dr. Reddy's Laboratories Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Pfizer Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Incyte Corporation
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. STRATA Skin Sciences
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Global Vitiligo Treatment Market Competitive Benchmarking

32. Global Vitiligo Treatment Market Competitive Dashboard

33. Key Mergers And Acquisitions In The Vitiligo Treatment Market

34. Vitiligo Treatment Market Future Outlook and Potential Analysis

  • 34.1 Vitiligo Treatment Market In 2028 - Countries Offering Most New Opportunities
  • 34.2 Vitiligo Treatment Market In 2028 - Segments Offering Most New Opportunities
  • 34.3 Vitiligo Treatment Market In 2028 - Growth Strategies
    • 34.3.1 Market Trend Based Strategies
    • 34.3.2 Competitor Strategies

35. Appendix

  • 35.1. Abbreviations
  • 35.2. Currencies
  • 35.3. Historic And Forecast Inflation Rates
  • 35.4. Research Inquiries
  • 35.5. The Business Research Company
  • 35.6. Copyright And Disclaimer